Garcia-Aguilar et al. reported that three individual genetic mutations, KRAS, CCND1, and MTHFR, were well correlated with a complete response (grade 0) to CRT in rectal carcinoma [30]. The gene discussed is CCND1; the disease is rectal carcinoma.